STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
Completed · Phase 4
Conditions studied: Neoplasms, Diarrhea
In brief
Currently there is an ongoing clinical trial for patients with chemotherapy induced diarrhea. This trial is being conducted to evaluate the efficacy of two dose levels (30 mg and 40 mg) of an investigational drug in reducing the occurrence of severe (Grade 3 or 4) diarrhea during chemotherapy. Eligible patients must either have experienced NCI Common Toxicity Grade 1 - 4 chemotherapy-induced diarrhea during previous chemotherapy treatment or be experiencing Grade 1-4 chemotherapy-induced diarrhea currently. In order to participate in this clinical trial, patients must be male or female 18 years of age or older. Inclusion into this investigational drug trial is based on the protocol entry criteria and a detailed evaluation from a participating trial investigator
Key facts
- Study ID
- NCT00050635
- Run by
- Novartis Pharmaceuticals
- People needed
- 150
- Starts
- 2002-12-01
- Expected to finish
- 2003-07-01
- Last updated by the study team
- 2009-11-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cancer Care Center — Bloomington, Indiana, United States
- Suniti Medical Corporation — Merrillville, Indiana, United States
- Genesys Hurley Cancer Institute — Flint, Michigan, United States
- Cancer & Hematology Centers of Western Michigan — Grand Rapids, Michigan, United States
- Delta Oncology — Greenwood, Mississippi, United States
- Missouri Cancer Associates — Columbia, Missouri, United States
- Heartland Hematology Oncology Associates — Kansas City, Missouri, United States
- Arch Medical Services/The Center for Cancer Care and Research — St Louis, Missouri, United States
- New Mexico Cancer Care Associates — Santa Fe, New Mexico, United States
- North Shore Hematology Oncology — East Setauket, New York, United States
- Raleigh Hematology Oncology Associates, Wake Practice — Raleigh, North Carolina, United States
- Dakota Clinic/Odyssey Research Services — Fargo, North Dakota, United States
- Nashat Y. Gabrail, MD — Canton, Ohio, United States
- North Coast Cancer Care, Inc. — Sandusky, Ohio, United States
- Lawrence M. Stallings, MD — Wooster, Ohio, United States
- Consultants in Medical Oncology-Hematology — Drexel Hill, Pennsylvania, United States
- Regional Hematology Oncology Assoc — Langhorne, Pennsylvania, United States
- Oncology Services of Aberdeen — Borden, South Dakota, United States
- Jones Oncolgy/Hematology Clinic — Germantown, Tennessee, United States
- McFaddin Ward Cancer - TOPA — Beaumont, Texas, United States
- Scott & White Hospital/CCPC — Waco, Texas, United States
- Oncology & Hematology Associates of SW VA — Roanoke, Virginia, United States
- Kenmar Research Institute — Burbank, California, United States
- Bay Area Cancer Research Group — Concord, California, United States
- Compassionate Cancer Care medical Group, Inc. — Fountain Valley, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.